Stereotaxis, Inc. (STXS) Financial Statements (2026 and earlier)

Company Profile

Business Address 710 N TUCKER BLVD
ST.LOUIS, MO 63101
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments12,21719,81828,43038,73943,94030,182
Cash and cash equivalent12,21719,8188,58638,73943,94030,182
Short-term investments   19,844   
Receivables3,8243,8225,0905,4063,5155,498
Inventory, net of allowances, customer advances and progress billings8,3318,4267,8764,4333,2951,848
Inventory8,3318,4267,8764,4333,2951,848
Other undisclosed current assets2,0671,2011,8502,8101,9671,302
Total current assets:26,43933,26743,24651,38852,71738,830
Noncurrent Assets
Operating lease, right-of-use asset5,4834,9825,3845,735 4,286
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization3,5733,3043,8312,632195250
Long-term investments and receivables      
Accounts and financing receivable, after allowance for credit loss      
Intangible asset, including goodwill, after accumulated amortization11,122     
Goodwill3,764     
Intangible asset, excluding goodwill, after accumulated amortization7,358     
Restricted cash and investments  219744952  
Other noncurrent assets    278309218
Other undisclosed noncurrent assets107137208 2,235 
Total noncurrent assets:20,2858,64210,1679,5962,7394,755
TOTAL ASSETS:46,72441,90953,41360,98555,45643,585
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities8,5906,1626,5766,7174,8184,820
Accounts payable5,6683,1903,2704,1881,6092,099
Accrued liabilities2,9222,9723,3062,5283,2092,721
Deferred revenue6,8046,6577,3426,2775,2835,092
Debt     1,1852,248
Business combination, contingent consideration, liability      
Other undisclosed current liabilities6,2084283732682,287 
Total current liabilities:21,60213,24714,29113,26213,57312,161
Noncurrent Liabilities
Long-term debt and lease obligation    5,8429732,090
Long-term debt, excluding current maturities     973 
Liabilities, other than long-term debt7,5646,7427,1932,457680810
Deferred revenue2,0641,6371,6542,238549554
Other liabilities644351219131256
Operating lease, liability5,4365,0625,4885,842 2,090
Business combination, contingent consideration, liability      
Other undisclosed noncurrent liabilities 6,126     
Total noncurrent liabilities:13,6906,7427,1938,2991,6532,899
Total liabilities:35,29219,98921,48421,56115,22715,060
Temporary equity, including noncontrolling interest5,3525,5775,5835,5845,6055,758
Equity
Equity, attributable to parent6,08016,34326,34633,84034,62422,766
Preferred stock   6666
Common stock858175757469
Treasury stock, value(206)(206)(206)(206)(206)(206)
Additional paid in capital567,926554,148543,438532,641522,710504,211
Accumulated deficit(561,725)(537,680)(516,967)(498,675)(487,959)(481,313)
Total equity:6,08016,34326,34633,84034,62422,766
TOTAL LIABILITIES AND EQUITY:46,72441,90953,41360,98555,45643,585

Income Statement (P&L) ($ in thousands)

12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Revenues26,91826,77128,14735,02126,63028,903
Cost of revenue(12,324)(11,911)(9,677)(11,789)(7,664)(6,136)
Gross profit:14,59414,86018,47023,23218,96622,766
Operating expenses(39,333)(36,699)(37,246)(36,120)(25,680)(27,593)
Operating loss:(24,739)(21,839)(18,776)(12,888)(6,714)(4,827)
Nonoperating income
(Other Nonoperating income)
      
Interest and debt expense    2,183  
Loss from continuing operations:(24,739)(21,839)(18,776)(10,706)(6,714)(4,827)
Loss before gain (loss) on sale of properties:(10,706)(6,714)(4,827)
Net loss:(24,739)(21,839)(18,776)(10,706)(6,714)(4,827)
Other undisclosed net income (loss) attributable to parent6941,126484(10)67236
Net loss attributable to parent:(24,045)(20,713)(18,292)(10,716)(6,646)(4,591)
Preferred stock dividends and other adjustments(1,308)(1,343)(1,343)(1,345)(1,369)(1,429)
Net loss available to common stockholders, diluted:(25,353)(22,056)(19,635)(12,061)(8,016)(6,021)

Comprehensive Income ($ in thousands)

12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net loss:(24,739)(21,839)(18,776)(10,706)(6,714)(4,827)
Comprehensive loss, net of tax, attributable to parent:(24,739)(21,839)(18,776)(10,706)(6,714)(4,827)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: